naltrexone and Obesity, Morbid

naltrexone has been researched along with Obesity, Morbid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kraft, K; Vetter, H	1

Reviews

1 review(s) available for naltrexone and Obesity, Morbid

Article	Year
Naltrexone/bupropion for obesity. Drug and therapeutics bulletin, 2017, Volume: 55, Issue:11 Topics: Anti-Obesity Agents; Bupropion; Chemotherapy, Adjuvant; Drug Combinations; Humans; Naltrexone; Obesity, Morbid; Randomized Controlled Trials as Topic	2017

Other Studies

1 other study(ies) available for naltrexone and Obesity, Morbid

Article	Year
Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1991, Volume: 23, Issue:2 Topics: Adult; Appetite; Drug Administration Schedule; Female; Humans; Hypopituitarism; Naltrexone; Obesity, Morbid; Prolactin; Vasopressins; Weight Loss	1991

Article

Year

Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1991, Volume: 23, Issue:2

Topics: Adult; Appetite; Drug Administration Schedule; Female; Humans; Hypopituitarism; Naltrexone; Obesity, Morbid; Prolactin; Vasopressins; Weight Loss

1991